IL26 and COVID-19: Importantly, patients with COVID-19 who took corticosteroids as part of their treatment had similar plasma concentrations of IL-26 and a similar number of measurements above the LLOD (χ2 test: p = 0.3608) than those who did not receive corticosteroids (Supplementary Figure 3).